Other Clinical Trial - to Evaluate the Safety/Tolerability &

See also
Status	Clinical Trial	Phase
Completed	`NCT04080726` - Efficacy and Safety of HIP1601 Capsule	Phase 3
Completed	`NCT00562094` - Efficacy of Pantoprazole in Patients Older Than 12 Years With Reflux Associated Sleep Disorders (PULS)	N/A
Completed	`NCT03184324` - Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Erosive Gastroesophageal Reflux Disease (Phase 2, Therapeutic Exploratory Study)	Phase 2

See also

Status

Clinical Trial

Phase

Completed

NCT04080726 - Efficacy and Safety of HIP1601 Capsule

Phase 3

Completed

NCT00562094 - Efficacy of Pantoprazole in Patients Older Than 12 Years With Reflux Associated Sleep Disorders (PULS)

N/A

Completed

NCT03184324 - Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Erosive Gastroesophageal Reflux Disease (Phase 2, Therapeutic Exploratory Study)

Phase 2

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT06437951
Study type	Interventional
Source	Daewoong Pharmaceutical Co. LTD.
Contact	Sujong Lee, Ph.D
Phone	027408910
Email	leesj0323@snu.ac.kr
Status	Not yet recruiting
Phase	Phase 1
Start date	July 2024
Completion date	May 2025

to Evaluate the Safety/Tolerability and Pharmacokinetics, and Pharmacodynamics of DWP14012 Injection

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms